Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

881
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
881
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Hematopoiesis01:21

Hematopoiesis

8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

Clinical pharmacology and therapeutics·2026
Same author

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis Following CAR T-Cell Therapy: Results of a Real-World Study.

Cancers·2026
Same author

Triple Iron Chelation in Transfusion Dependent Thalassemia: A Case Report.

Journal of clinical medicine·2026
Same author

Pernicious Anemia Resulting in Intramedullary Hemolysis, Masking Underlying Polycythemia Vera and Mild Alpha-Thalassemia-A Case Report.

Case reports in hematology·2026
Same author

Plasma heme pool compartmentalization is linked to pathophysiology in Sickle Cell Disease.

PloS one·2026
Same journal

Progression-free survival effect sizes in randomized controlled trials of targeted cancer therapies with positive outcomes.

Acta haematologica·2026
Same journal

Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.

Acta haematologica·2026
Same journal

Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.

Acta haematologica·2026
Same journal

Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

Acta haematologica·2026
Same journal

Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

Acta haematologica·2026
Same journal

Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.

Acta haematologica·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.5K

Artificial Intelligence in Haematologic Diagnostics: Current Applications and Future Perspectives.

Annatina Sarah Schnegg-Kaufmann1,2, Ulrike Bacher1,2, Alicia Rovó1,2

  • 1Department of Hematology and Central Hematology Laboratory, Inselspital Bern, University of Bern, Bern, Switzerland.

Acta Haematologica
|October 13, 2025
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) is enhancing haematological diagnostics through automation in areas like cell differentiation and flow cytometry. While promising, AI requires further validation and ethical considerations, with expert interpretation remaining crucial.

Keywords:
Artificial intelligenceCytomorphologyFlow cytometryGenomicsHaemostasis

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

800
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.2K

Related Experiment Videos

Last Updated: Jan 15, 2026

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.5K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

800
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.2K

Area of Science:

  • Hematology
  • Medical Diagnostics
  • Artificial Intelligence

Background:

  • Growing demand for efficient and accurate diagnoses drives exploration of AI in hematology.
  • Clinical researchers and lab specialists are investigating AI to optimize diagnostic processes.

Purpose of the Study:

  • To review current AI applications in hematological diagnostics.
  • To summarize AI integration in cytomorphology, flow cytometry, genetics, and hemostasis.

Main Methods:

  • Review of existing literature on AI in hematology.
  • Analysis of AI applications in automated cell differentiation, anemia diagnosis, and acute leukemia detection.
  • Examination of AI's role in flow cytometry, genomics, and hemostasis.

Main Results:

  • AI facilitates automated cell differentiation, anemia diagnosis, and acute leukemia identification.
  • AI integration in flow cytometry may reduce subjectivity; machine learning aids genomic data processing.
  • AI enables automation in hemostasis quality control and personalized reference ranges.

Conclusions:

  • AI shows significant promise for automating and improving hematological diagnostics.
  • Challenges include cross-platform compatibility, validation, and ethical concerns like bias.
  • Expert hematologist interpretation remains essential for final diagnosis.